Max Healthcare Institute Ltd
MAXHEALTHMax Healthcare Institute Ltd
MAXHEALTH
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 91.59 | 11.54 | 0.15% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 49.70 | 6.30 | 0.53% |
Forecast & Ratings
Detailed Forecast from 17 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Max Healthcare is provider of home health care services including Patient Care, Healthcare Services, and Hospitals.
Peers
Compare with peersApollo Hospitals Enterprise Ltd
Fortis Healthcare Ltd
Global Health Ltd
Narayana Hrudayalaya Ltd
Dr. Lal PathLabs Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,470.54 | 1,667.82 | 1,794.47 | 1,748.07 | 1,956.85 | 2,619.41 | 4,290.79 | 4,970.61 | 5,882.27 | 6,175.07 | ||||||||||
Raw Materials | 403.39 | 423.00 | 431.05 | 362.20 | 409.14 | 580.51 | 930.46 | 936.88 | 1,119.04 | 4,402.94 | ||||||||||
| Power & Fuel Cost | 40.73 | 40.90 | 41.36 | 46.06 | 38.93 | 51.37 | 62.67 | 69.04 | 77.54 | |||||||||||
| Employee Cost | 304.74 | 353.47 | 422.91 | 440.55 | 449.24 | 588.78 | 768.95 | 810.04 | 937.12 | |||||||||||
| Selling & Administrative Expenses | 168.55 | 593.95 | 647.99 | 630.23 | 191.43 | 208.86 | 510.39 | 631.33 | 741.49 | |||||||||||
| Operating & Other expenses | 413.13 | 56.61 | 72.57 | 56.80 | 506.63 | 904.99 | 957.43 | 1,143.55 | 1,336.89 | |||||||||||
EBITDA | 140.00 | 199.89 | 178.59 | 212.23 | 361.48 | 284.90 | 1,060.89 | 1,379.77 | 1,670.19 | 1,772.13 | ||||||||||
| Depreciation/Amortization | 91.21 | 95.51 | 94.42 | 102.64 | 119.74 | 174.09 | 221.12 | 232.19 | 244.98 | 292.33 | ||||||||||
| PBIT | 48.79 | 104.38 | 84.17 | 109.59 | 241.74 | 110.81 | 839.77 | 1,147.58 | 1,425.21 | 1,479.80 | ||||||||||
| Interest & Other Items | 67.75 | 99.68 | 99.37 | 101.27 | 152.66 | 179.46 | 100.87 | 83.86 | 59.89 | 89.39 | ||||||||||
| PBT | -18.96 | 4.70 | -15.20 | 8.32 | 89.08 | -68.65 | 738.90 | 1,063.72 | 1,365.32 | 1,390.41 | ||||||||||
| Taxes & Other Items | 3.65 | -11.09 | 9.95 | 11.33 | -6.26 | 68.90 | 133.85 | -39.79 | 307.68 | 331.45 | ||||||||||
| Net Income | -22.61 | 15.79 | -25.15 | -3.01 | 95.34 | -137.55 | 605.05 | 1,103.51 | 1,057.64 | 1,058.96 | ||||||||||
| EPS | -0.44 | 0.29 | -0.47 | -0.06 | 1.77 | -1.83 | 6.25 | 11.37 | 10.89 | 10.90 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.50 | 1.50 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.14 | 0.14 |
Company Updates
Annual report
PDFPeers & Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Max Healthcare Institute Ltd | 91.70 | 11.54 | 0.15% |
| Apollo Hospitals Enterprise Ltd | 106.99 | 13.13 | 0.24% |
| Fortis Healthcare Ltd | 82.92 | 5.80 | 0.15% |
| Global Health Ltd | 81.25 | 10.29 | — |
Price Comparison
Compare MAXHEALTH with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Max Healthcare Institute Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
HDFC Mid-Cap Opportunities Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.6051% | Percentage of the fund’s portfolio invested in the stock 2.07% | Change in the portfolio weight of the stock over the last 3 months -0.71% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 14/79 (-5) |
SBI Equity Hybrid Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.8666% | Percentage of the fund’s portfolio invested in the stock 1.12% | Change in the portfolio weight of the stock over the last 3 months 0.13% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 23/96 (0) |
Motilal Oswal Midcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.7868% | Percentage of the fund’s portfolio invested in the stock 3.81% | Change in the portfolio weight of the stock over the last 3 months 0.93% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 11/29 (+2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 23, 2024
Dividend/Share
₹1.50
Ex DateEx Date
Aug 23, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Dividend/Share
₹1.00
Ex DateEx Date
Sep 8, 2023
Max Healthcare Institute has completed the acquisition 100% equity stake of Jaypee Healthcare (JHL) on 11 November 2024, upon acquisition of remaining 15,53,90,769 equity shares constituting to 36.35% equity stake for an aggregate consideration of Rs 227 crore. Consequently, JHL has become a wholly-owned subsidiary of the Company.Powered by Capital Market - Live
Net profit of Max Healthcare Institute rose 1.85% to Rs 281.81 crore in the quarter ended September 2024 as against Rs 276.68 crore during the previous quarter ended September 2023. Sales rose 25.26% to Rs 1707.46 crore in the quarter ended September 2024 as against Rs 1363.16 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1707.461363.16 25 OPM %26.3928.42 - PBDT457.84424.30 8 PBT373.69366.42 2 NP281.81276.68 2 Powered by Capital Market - Live
Max Healthcare Institute will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live
Max Healthcare Institute announced that Kummamuri Narasimha Murthy (DIN: 00023046) completed his second consecutive term as an Independent Director of the Company on 25 September 2024 and consequently ceased to be a Director of the Company with effect from end of the day on 25 September 2024.Powered by Capital Market - Live
Max Healthcare Institute has allotted 2,06,091 equity shares under ESOS on 13 September 2024. With this allotment, the paid up equity share capital has increased to 97,21,32,053 equity shares of Rs 10 each. Powered by Capital Market - Live
The Board of Max Healthcare Institute at its meeting held on 13 September 2024 has approved execution of strategic collaboration agreement with Lakshdeep Investments and Finance and Lakshdeep Infrastructure and Holdings (collectively referred to as 'Lakshdeep Group'). Lakshdeep Group entities are indirect holding companies of Jaypee Healthcare ('JHL') who have been permitted to work out / submit a viable plan/solution in relation to the revival of JHL vide order dated 11 July 2024 of Hon'ble National Company Law Appellate Tribunal ('NCLAT'), Delhi. The NCLAT has approved the settlement agreed to between Lakhsdeep Group and the Committee of Creditors of JHL ('CoC') vide its order dated 12 September 2024. The Company, as strategic partner under the aforesaid arrangement, shall enter into an agreement to acquire ~64% equity stake of JHL within 30 days of NCLAT order. The Company proposes to enter into option agreement for acquisition of remaining ~36% equity stake. The Board has also approved raising of funds by way of short term loans at the Company level up to Rs 1,000 Crore for settlement of admitted claims of the financial creditor of JHL and utilization of internal accruals of the Company for the proposed purchase of equity shares of JHL. Further, the Company shall also organize loan at JHL level for the repayment of its short term debt.In this regard, the Board has also approved issuance of corporate guarantee to the bank/ financial institution for loan proposed to be extended to JHL. Powered by Capital Market - Live
Max Healthcare Institute (MHIL) has entered into a Strategic Collaboration Agreement with Lakshdeep Group, the ultimate promoter group of Jaypee Healthcare (JHL) - which is undergoing Corporate Insolvency Resolution Process (CIRP). This Strategic Collaboration and proposed acquisition will give MHIL a controlling stake in JHL, including its flagship asset, the renowned 500-beds Jaypee Hospital, Noida. Under the agreement, MHIL shall organize debt for repayment of admitted claims of the financial creditors of JHL and proposes to simultaneously acquire ~64% stake in the company, with call and put option for the remaining stake. The acquisition is based on an enterprise value of Rs 1,660 crore, reflecting JHL's strong market position, which includes two operational hospitals i.e. 500-bedsJaypee Hospital, Noida and 200-beds Jaypee Hospital Bulandshahr, built on land parcel of 18 acre and 5.75 acre respectively. Further JHL also owns a 100-beds hospital spread over 2.35 acres at Anoopshahar, which is currently non-operational. JHL reported revenue of Rs 421 crore and EBITDA of Rs 70 crore for the year 2023-24. The transaction, which includes the Strategic Collaboration Agreement and the acquisition of JHL's stake held by financial creditors, shall be consummated in next thirty days in line with the revival plan approved by the Hon'ble National Company Law Appellate Tribunal (NCLAT). The revival plan is designed to provide sustainability to the operations of Jaypee Hospitals through appropriate measures to enhance operational efficiency while building confidence among various stakeholders. With the proposed transaction and collaboration with Max Healthcare as strategic partner to the revival plan, JHL is well positioned for potential growth and continued services to the community.Powered by Capital Market - Live
Max Healthcare Institute announced that the 23th Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
Max Healthcare shares down 0.28% as Sensex rises
Buy Max Healthcare Institute, target price Rs 975: Prabhudas Lilladher
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 27.47%, vs industry avg of 10.02%
Increasing Market Share
Over the last 5 years, market share increased from 4.77% to 9.53%